The use of Multidimensional Data to Identify the Molecular Biomarker for Pancreatic Ductal Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease, and the patient has an extremely poor overall survival with a less than 5% 5-year survival rate. Development of potential biomarkers provides a critical foundation for the diagnosis of PDAC. In this project, we have adopted an integrative...
Main Authors: | , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793503/ |